Tarsier Pharma Ltd.

Tarsier Pharma Ltd. (TARX) has logged zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in our near-term monitoring window. However, low signal in a three-month snapshot does not eliminate risk; the biotech sector faces persistent pressures from financing cycles, equity dilution, and clinical development timelines that require deeper context. The full $49 Report pulls 12 months of filing history, calculates dilution risk scoring, maps financing events, and flags AI-detected risk signals that our initial scan cannot surface. The full $49 Report adds comprehensive dilution analysis, historical 8-K context, and quantified risk scoring across a full-year horizon.